Nu-Med Plus (NUMD) Return on Capital Employed (2013 - 2025)
Nu-Med Plus recorded quarterly Return on Capital Employed of 17.95% in Q4 2025, down 4.81% quarter-over-quarter from 18.86% in Q3 2025, and down 1132.0% year-over-year from 1.74% in Q4 2024.
Nu-Med Plus' Return on Capital Employed history runs 13 years deep, the most recent figure standing at 17.95% for Q4 2025.
- In Q4 2025, Return on Capital Employed fell 1132.0% year-over-year to 17.95%; the TTM figure through Dec 2025 stood at 17.95% (down 1132.0% YoY), while the FY2025 annual figure was 18.09%, down 1163.0% from the prior year.
- Return on Capital Employed came in at 17.95% for Q4 2025 at Nu-Med Plus, down from 18.86% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2413.52% in Q3 2021 to a low of 1624.23% in Q2 2021.
- A 5-year average of 114.96% and a median of 63.99% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed surged 601165 bps in 2021 and tumbled 230581 bps in 2022, its largest moves.
- Nu-Med Plus' Return on Capital Employed stood at 712.47% in 2021, then slumped by 75 bps to 179.98% in 2022, then tumbled by 54 bps to 82.21% in 2023, then plunged by 64 bps to 29.27% in 2024, then tumbled by 39 bps to 17.95% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 17.95%, 18.86%, and 22.49% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Nu-Med Plus | - | - | - | 17.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.95% |
| Sep 30, 2025 | 18.86% |
| Jun 30, 2025 | 22.49% |
| Mar 31, 2025 | 26.38% |
| Dec 31, 2024 | 29.27% |
| Sep 30, 2024 | 54.03% |
| Jun 30, 2024 | 57.31% |
| Mar 31, 2024 | 68.61% |
| Dec 31, 2023 | 82.21% |
| Sep 30, 2023 | 59.38% |
| Jun 30, 2023 | 109.78% |
| Mar 31, 2023 | 184.57% |
| Dec 31, 2022 | 179.98% |
| Sep 30, 2022 | 107.71% |
| Jun 30, 2022 | 140.87% |
| Mar 31, 2022 | 298.17% |
| Dec 31, 2021 | 712.47% |
| Sep 30, 2021 | 2,413.52% |
| Jun 30, 2021 | -1,624.23% |
| Mar 31, 2021 | -660.06% |
| Dec 31, 2020 | -384.68% |
| Sep 30, 2020 | -515.42% |
| Jun 30, 2020 | -7,635.87% |
| Mar 31, 2020 | 202.42% |
| Dec 31, 2019 | 290.03% |
| Sep 30, 2019 | 366.67% |
| Jun 30, 2019 | 602.58% |
| Mar 31, 2019 | 1,625.82% |
| Dec 31, 2018 | -1,049.72% |
| Sep 30, 2018 | 3,380.38% |
| Jun 30, 2018 | -14,129.23% |
| Mar 31, 2018 | 12,378.27% |
| Dec 31, 2017 | 3,401.70% |
| Sep 30, 2017 | -4,576.74% |
| Jun 30, 2017 | -94.46% |
| Mar 31, 2017 | 2.09% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | -61.14% |
| Jun 30, 2016 | 156.69% |
| Mar 31, 2016 | -18.97% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 664.12% |
| Jun 30, 2015 | 709.24% |
| Mar 31, 2015 | 906.85% |
| Dec 31, 2014 | 2,131.69% |
| Sep 30, 2014 | -631.55% |
| Jun 30, 2014 | -189.41% |
| Mar 31, 2014 | -922.64% |
| Sep 30, 2013 | 321.99% |
| Jun 30, 2013 | 240.30% |